Annette J. Vangsted, Tobias W. Klausen, Peter Gimsing, Niels F. Andersen, Niels Abildgaard, Henrik Gregersen, Ulla Vogel. A polymorphism in NFKB1 is associated with improved effect of interferon-α maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support. Haematologica 2009;94(9):1274-1281; https://doi.org/10.3324/haematol.2008.004572.